APT Medical

APT Medical Liabilities

The The Liabilities of APT Medical (688617.SS) as of Nov 4, 2026 is 477.40 M CNY. In the previous year, The Liabilities was 425.85 M CNY — a change of 12.10% (higher).

Liabilities

477.40 MCNY

YoY

12.10%

Last updated:

In 2025, APT Medical's total liabilities amounted to 477.40 M CNY, a 12.10% difference from the 425.85 M CNY total liabilities in the previous year.

The APT Medical Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
55.12 M CNY
Jan 1, 2019
215.13 M CNY
Jan 1, 2020
138.62 M CNY
Jan 1, 2021
222.02 M CNY
Jan 1, 2022
434.91 M CNY
Jan 1, 2023
610.98 M CNY
Jan 1, 2024
425.85 M CNY
Jan 1, 2025
477.40 M CNY
The APT Medical Liabilities history
YEARLiabilitiesYoY
477.40 MCNY+12.10%
425.85 MCNY-30.30%
610.98 MCNY+40.48%
434.91 MCNY+95.89%
222.02 MCNY+60.16%
138.62 MCNY-35.56%
215.13 MCNY+290.28%
55.12 MCNY+43.89%
38.31 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

APT Medical Stock analysis

What does APT Medical do? APT Medical Inc generates revenue through the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company offers electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters, and multichannel electrophysiological systems under its electrophysiology product line. Its coronary access segment includes guide wires, micro catheters, balloons, contrast guide wires, and catheters. Peripheral vascular intervention products address peripheral vascular diseases and are sold domestically and internationally. The firm also engages in original equipment manufacturer (OEM) business, producing products for other brands. Domestic and overseas markets are the primary sales channels for all product segments. The company's electrophysiology products target healthcare providers specializing in cardiac procedures, while coronary access devices serve interventional cardiologists and vascular surgeons. Peripheral vascular intervention solutions are marketed to hospitals and clinics treating vascular conditions. OEM partnerships allow APT Medical to supply components to other medical device manufacturers without direct branding. These segments collectively drive revenue through direct sales to healthcare institutions and international distributors. APT Medical Inc's product portfolio includes electrophysiological systems and coronary access tools that cater to specific medical specialties. The firm's peripheral vascular intervention products are designed for treating conditions like peripheral artery disease. OEM business contributes to revenue by manufacturing components for other companies' branded products. Domestic market sales and overseas distribution networks form the core of the company's commercial strategy, with no mention of specific customer names or financial figures beyond the employee count. APT Medical is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing APT Medical's Liabilities

APT Medical's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating APT Medical's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing APT Medical's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

APT Medical's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in APT Medical’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about APT Medical stock

The Liabilities of APT Medical is 477.40 M CNY in 2025.

The Liabilities of APT Medical changed from 425.85 M CNY to 477.40 M CNY, representing a 12.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities APT Medical since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's APT Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — APT Medical

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — APT Medical